|
Volumn 352, Issue 25, 2005, Pages 2645-2646
|
How Ebola virus infects cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLYCOPROTEIN 160;
GLYCOPROTEIN GP 120;
GLYCOPROTEIN GP 160;
GLYCOPROTEIN GP 41;
HYBRID PROTEIN;
UNCLASSIFIED DRUG;
VIRUS ENVELOPE PROTEIN;
VIRUS GLYCOPROTEIN;
CATHEPSIN;
CATHEPSIN B;
CATHEPSIN L;
CYSTEINE PROTEINASE;
CYSTEINE PROTEINASE INHIBITOR;
ENVELOPE GLYCOPROTEIN, EBOLA VIRUS;
ANGOLA;
ARTICLE;
CELL MEMBRANE;
EBOLA VIRUS;
EPIDEMIC;
HEMORRHAGIC FEVER;
HOST CELL;
HOST PATHOGEN INTERACTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
MORTALITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN CONFORMATION;
PROTEIN DOMAIN;
PROTEIN FUNCTION;
VIRUS VIRULENCE;
ANIMAL;
DRUG ANTAGONISM;
METABOLISM;
ANIMALS;
CATHEPSIN B;
CATHEPSINS;
CYSTEINE ENDOPEPTIDASES;
CYSTEINE PROTEINASE INHIBITORS;
EBOLAVIRUS;
HUMANS;
VIRAL ENVELOPE PROTEINS;
|
EID: 20544448655
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMcibr051754 Document Type: Article |
Times cited : (19)
|
References (5)
|